Trials

  • July 21, 2016

    Abbott Can't Put Depakote Blame On FDA, Mom Tells 6th Circ.

    A mother who lost a trial over her claims that Abbott and AbbVie Inc.'s epilepsy drug Depakote caused her child's birth defects urged the Sixth Circuit on Wednesday to grant her a new trial, saying the court wrongfully let the drugmaker "hide behind the FDA" and excluded crucial trial testimony.

  • July 21, 2016

    Google Blasts Oracle Trial Bid, Renews Orrick Sanctions Call

    Google Inc. on Wednesday defended a high-profile jury verdict that its use of Oracle’s copyrighted Java software code was protected by fair use, telling a California federal court Oracle shouldn’t get a new trial and reviving a sanctions bid against Orrick Herrington & Sutcliffe LLP partner Annette Hurst.

  • July 21, 2016

    SEC Fights Testimony Exclusion In Investment Co. Suit

    The U.S. Securities and Exchange Commission is defending its proposed witnesses in a suit against defunct investment advisory outfit The Nutmeg Group LLC over undisclosed funds transfers, telling an Illinois federal court on Wednesday they are more than qualified.

  • July 21, 2016

    Cabot Says It Was Dinged $4M For Pre-Existing Pollution

    Cabot Oil & Gas Corp. is not backing down from its fight for a new trial after two Pennsylvania families won $4 million over contaminated groundwater near the company's Susquehanna County fracking operations, telling a federal court Wednesday the verdict was reached on shoddy evidence.

  • July 21, 2016

    Trial Pros: Arnold & Itkin's Kurt Arnold

    Nothing matters if you don’t get the right jury. I think 90 percent of the job is done the moment the judge swears in the jury, says Kurt Arnold, co-founder of Arnold & Itkin LLP.

  • July 21, 2016

    Trial Pros: BraunHagey's Noah Hagey

    Late night coffee has probably contributed to more good ideas inside and outside the legal profession than any other vehicle, says Noah Hagey, founder and managing partner of BraunHagey & Borden LLP.

  • July 21, 2016

    Exxon Expert Admits Price Error In Lehman Securities Trial

    An expert witness called by Exxon Mobil Corp. to price securities at the center of a multimillion-dollar dispute with failed bank Lehman Brothers was forced to admit in a London court Thursday that he was wrong in his calculations.

  • July 20, 2016

    MetLife Owes For Agents' Role In $216M Ponzi Scam, Jury Told

    A woman who was among hundreds of investors claiming MetLife agents tricked them into buying unregistered securities from an alleged $216 million Ponzi scheme urged a California jury Wednesday to find the insurer liable for her losses, saying MetLife allowed its agents to solicit investors for the scheme.

  • July 20, 2016

    Nichia Pushes Fed. Circ. To Overturn Gilstrap Injunction Ruling

    Nichia Corp. has again pushed the Federal Circuit to reverse U.S. District Judge Rodney Gilstrap’s ruling denying a permanent injunction to block a rival from selling products he ruled infringe Nichia LED semiconductor patents.

  • July 20, 2016

    Presidio Seeks To Add To $2.1M Patent Infringement Verdict

    Presidio Components Inc. urged a California federal judge Wednesday to add supplemental damages and interest to a jury's $2.1 million verdict finding American Technical Ceramics Corp. infringed Presidio's patent for ceramic capacitors, saying wrongdoers shouldn't be able to escape compensating patentholders for the time between verdict and judgment.

  • July 20, 2016

    Surgery Center Can't Trim Meningitis MDL, Tenn. Judge Told

    Consumers in multidistrict litigation over a deadly 2012 meningitis outbreak urged a Massachusetts federal judge Wednesday not to let a Tennessee surgical center shake claims under that state's product liability law, arguing doctors providing medical services can be held liable like retailers selling goods.

  • July 20, 2016

    Patent Jury Trials At Risk, High Court Told In Cisco Case

    Expressing concern that patent owners’ right to a jury trial was being eroded, a small-business group and a consulting firm urged the U.S. Supreme Court to hear Commil USA LLC’s appeal of a Federal Circuit ruling that vacated a $74 million verdict against Cisco Systems Inc.

  • July 20, 2016

    Atty Who Quit Before $27M BofA Verdict Still Gets Fees

    A Massachusetts attorney with a contingency agreement should get fees after representing a car dealership for 17 years in a suit against Bank of America NA, even though he bowed out before a third trial and $27 million verdict, the Massachusetts Appeals Court ruled Wednesday.

  • July 20, 2016

    Diabetes Test Co. Says Jury Right To Deny $1M In Legal Fees

    A Florida diabetes test supply company urged the Eleventh Circuit Tuesday to uphold a jury verdict that rejected intellectual property firm Stein Law PC's claims for $1 million in legal fees, arguing that the firm presented nothing to justify overturning the decision.

  • July 20, 2016

    Blackberry Beats $48M Patent Claim After Texas Trial

    A Texas federal jury on Wednesday found Blackberry Corp. network infrastructure did not infringe a patent that was key in establishing two-way pager networks, handing the company a win after the patent owner sought $47.9 million in royalties, according to court records.

  • July 20, 2016

    Defense Contractor Found Guilty Of Selling DOD Lousy Parts

    An Ohio federal jury on Wednesday convicted the president of a defense contracting company on charges that he sold to the U.S. Department of Defense substandard weapons system components.

  • July 20, 2016

    Ex-Acclarent Execs Beat Felony Off-Label Fraud Charges

    A Massachusetts federal jury acquitted two top former Acclarent executives Wednesday of a slew of felony fraud charges related to the company's promotion of a medical device off-label, but convicted the pair of 10 misdemeanor counts of introducing a misbranded and adulterated device into interstate commerce.

  • July 20, 2016

    Trial Pros: Bradshaw & Associates' Drexel Bradshaw

    When it’s time to examine adverse witnesses, I ignore the outline and do my own thing. No one can write a cross-examination for a trial lawyer — it’s like trying to paint a canvas for another artist, says Drexel Bradshaw, principal of Bradshaw & Associates PC.

  • July 20, 2016

    Houston Doctor Gets 5 Years For Medicare Fraud

    A Houston doctor will serve more than five years in federal prison after a jury convicted him of falsely certifying Medicare beneficiaries for home health care services for which they were ineligible, the U.S. Department of Justice announced Tuesday.

  • July 20, 2016

    Merck Asks To Wait For Fed. Circ. In Gilead Atty Fees Row

    The Federal Circuit needs to decide whether a California federal judge was right to overturn a jury’s $200 million verdict in favor of Merck & Co. in a patent dispute over hepatitis C drugs before the judge can decide on Gilead’s $15.5 million attorneys’ fees request, Merck said Tuesday.